172 related articles for article (PubMed ID: 12960655)
1. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin.
Ciamarra P; Nurko S; Barksdale E; Fishman S; Di Lorenzo C
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):315-9. PubMed ID: 12960655
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
Chumpitazi BP; Fishman SJ; Nurko S
Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
[TBL] [Abstract][Full Text] [Related]
3. The treatment of internal anal sphincter achalasia with botulinum toxin.
Messineo A; Codrich D; Monai M; Martellossi S; Ventura A
Pediatr Surg Int; 2001 Sep; 17(7):521-3. PubMed ID: 11666049
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin injection for childhood constipation is safe and can be effective regardless of anal sphincter dynamics.
Zar-Kessler C; Kuo B; Belkind-Gerson J
J Pediatr Surg; 2018 Apr; 53(4):693-697. PubMed ID: 29395154
[TBL] [Abstract][Full Text] [Related]
6. Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.
Friedmacher F; Puri P
Pediatr Surg Int; 2012 Aug; 28(8):765-71. PubMed ID: 22806601
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction.
Irani K; Rodriguez L; Doody DP; Goldstein AM
Pediatr Surg Int; 2008 Jul; 24(7):779-83. PubMed ID: 18443801
[TBL] [Abstract][Full Text] [Related]
8. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications.
Halleran DR; Lu PL; Ahmad H; Paradiso MM; Lehmkuhl H; Akers A; Hallagan A; Bali N; Vaz K; Yacob D; Di Lorenzo C; Levitt MA; Wood RJ
J Pediatr Surg; 2019 Nov; 54(11):2305-2310. PubMed ID: 31060739
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous needle-free injection of botulinum toxin: a novel treatment of childhood constipation and anal fissure.
Keshtgar AS; Ward HC; Clayden GS
J Pediatr Surg; 2009 Sep; 44(9):1791-8. PubMed ID: 19735827
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
Langer JC; Birnbaum E
J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
[TBL] [Abstract][Full Text] [Related]
11. Treatment with botulinum toxin in children with chronic anal fissure.
Husberg B; Malmborg P; Strigård K
Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
[TBL] [Abstract][Full Text] [Related]
13. Intrarectal Electromotive Botulinum Toxin Type A Administration in Children With Intractable Constipation: A Randomized Clinical Trial.
Kajbafzadeh AM; Sharifi-Rad L; Nabavizadeh B; Ladi-Seyedian SS; Alijani M; Farahmand F; Motamed F; Alimadadi H; Fallahi A; Fallahi GH
Am J Gastroenterol; 2020 Dec; 115(12):2060-2067. PubMed ID: 33009066
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blind randomized trial.
Keshtgar AS; Ward HC; Sanei A; Clayden GS
J Pediatr Surg; 2007 Apr; 42(4):672-80. PubMed ID: 17448764
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of the use of botulinum toxin injection for functional anal pain.
Hollingshead JR; Maeda Y; Brown TJ; Warusavitarne J; Vaizey CJ
Colorectal Dis; 2011 Sep; 13(9):e293-6. PubMed ID: 21689353
[TBL] [Abstract][Full Text] [Related]
16. Botulin toxin in the treatment of nonrelaxing puborectalis syndrome.
Shafik A; El-Sibai O
Dig Surg; 1998; 15(4):347-51. PubMed ID: 9845612
[TBL] [Abstract][Full Text] [Related]
17. Fissurectomy combined with anoplasty and injection of botulinum toxin in treatment of anterior chronic anal fissure with hypertonia of internal anal sphincter: a pilot study.
Patti R; Famà F; Tornambè A; Asaro G; Di Vita G
Tech Coloproctol; 2010 Mar; 14(1):31-6. PubMed ID: 20127381
[TBL] [Abstract][Full Text] [Related]
18. Excellent response rate of anismus to botulinum toxin if rectal prolapse misdiagnosed as anismus ('pseudoanismus') is excluded.
Hompes R; Harmston C; Wijffels N; Jones OM; Cunningham C; Lindsey I
Colorectal Dis; 2012 Feb; 14(2):224-30. PubMed ID: 21689279
[TBL] [Abstract][Full Text] [Related]
19. Histology and function of the internal anal sphincter after injection of botulinum toxin.
Langer JC; Birnbaum EE; Schmidt RE
J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
[TBL] [Abstract][Full Text] [Related]
20. Partial lateral internal sphincterotomy versus combined botulinum toxin A injection and topical diltiazem in the treatment of chronic anal fissure: a randomized clinical trial.
Gandomkar H; Zeinoddini A; Heidari R; Amoli HA
Dis Colon Rectum; 2015 Feb; 58(2):228-34. PubMed ID: 25585082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
